Building access to the Regenstrief Institute is restricted at least through May 3, 2020. More on our coronavirus precautions.
See our coronavirus precautions.
Drs. Callahan and Torke are leading a core of a national Alzheimer's research incubator.

Regenstrief researchers Christopher M. Callahan, M.D., and Alexia M. Torke, M.D., are leading the training core of a major national research incubator with the goal of improving healthcare and quality of life for people with Alzheimer’s disease and related dementias. Dr. Callahan and Dr. Torke will develop and coordinate a two-year junior career development award program to train researchers to conduct embedded pragmatic clinical trials in people living with dementia. The scientists trained will help to develop and test solutions to improve care for the growing population of people suffering from the disease.

Read more.

Related Influence

Mar 23, 2020 • Influence
LOINC leads during coronavirus pandemic
LOINC team’s nimble response provides help to track virus LOINC®, a universal medical coding system maintained at Regenstrief Institute, has been a leader in fostering communication during the global COVID-19 pandemic. As the virus was first identified, the LOINC team created universal codes to identify lab tests and results related to SARS-CoV-2 and COVID-19. These…
Continue Reading >
Mar 17, 2020 • Influence
Regenstrief VP highlights dangerous potential of coronavirus in national news outlets
In a New York Times article and several national interviews, Aaron Carroll, M.D., Regenstrief Institute vice president for faculty development and a nationally recognized health expert, expressed his concern about the potential for the coronavirus (COVID-19) to overwhelm the U.S. healthcare system if action is not taken to slow its spread. “As a medical doctor…
Continue Reading >